Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 5, 2003, Pages 1404-1410

  Xia, Zhengyuan ^a,b   Gu, Jiazhen ^a   Ansley, David M ^b   Xia, Fang ^a   Yu, Jinfu ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTIOXIDANT; CREATINE KINASE MB; DOPAMINE; ENDOTHELIN 1; HEART ENZYME; MALONALDEHYDE; PHENOL; PROSTACYCLIN; SALVIA MILTIORRHIZA EXTRACT; THROMBOXANE A2; THROMBOXANE B2;

ANESTHESIA; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; LUNG DISEASE; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SALVIA MILTIORRHIZA; VENOUS BLOOD; WARMING;

EID: 0344494039     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00970-X     Document Type: Article

References (30)

1. Hill GE, Whiteen CW. The role of the vascular endothelium in inflammatory syndromes, atherogenesis, and the propagation disease. J Cardiothorac Vasc Anesth. 1997;11:316-21.
2. Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol. 1996; 271(6 Pt 2):H2629-37.
3. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation. 1997;95:1918-29.
4. Bond BR, Dorman BH, Clair MJ, Walker CA, Pinosky ML, Reeves ST, et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg. 2001;122:358-64.
5. Joffs C, Walker CA, Hendrick JW, Fary DJ, Almany DK, Davis JN, et al. Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;122:365-70.
6. Hiramatsu T, Imai Y, Takanashi Y, Hoshino S, Yashima M, Tanaka SA, et al. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects. Ann Thorac Surg. 1997;63:648-52.
7. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg. 1993;106:473-8.
8. Dorman BH, Bond BR, Clair MJ, Walker CA, Pinosky ML, Reeves ST, et al. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anesth. 2000;14:540-5.
9. Bando K, Vijay P, Turrentine MW, Sharp TG, Means LJ, Ensing GJ, et al. Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Surg. 1998;115:517-27.
10. Todoki K, Okabe E, Kiyose T, Sekishita T, Ito H. Oxygen free radical-mediated selective endothelial dysfunction in isolated coronary artery. Am J Physiol. 1992;262(3 Pt 2):H806-12.
11. Sellke FW, Shafique T, Ely DL, Weintraub RM. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation. 1993;88(5 Pt 2):II395-400.
12. Clermont G, Vergely C, Jazayeri S, Lahet JJ, Goudeau JJ, Lecour S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80-7.
13. Boulanger CM. Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol. 1999;31:39-49.
14. Kahler J, Ewert A, Weckmuller J, Stobbe S, Mittmann C, Koster R, et al. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol. 2001;38: 49-57.
15. Ylikorkala O, Saarela E, Viinikka L. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;82:245-7.
16. Greeley WJ, Bushman GA, Kong DL, Oldham HN, Peterson MB. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg. 1988;95:842-9.
17. Zhao BL, Jiang W, Zhao Y, Hou JW, Xin WJ. Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int. 1996;38:1171-82.
18. Liu GT, Zhang TM, Wang BE, Wang YW. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol. 1992;43:147-52.
19. McColl AJ, Keeble T, Hadjinikolaou L, Cohen A, Aitkenhead H, Glenville B, et al. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem. 1998;35(Pt 5):616-23.
20. Barta E, Pechan I, Cornak V, Luknarova O, Rendekova V, Verchovodko P. Protective effect of alpha-tocopherol and L-ascorbic acid against the ischemic-reperfusion injury in patients during open-heart surgery. Bratisl Lek Listy. 1991;92:174-83.
21. Ji XY, Tan BK, Zhu YZ. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sin. 2000;21:1089-94.
22. Liu P, Hu Y, Liu C, Liu C, Zhu D. Effects of salviainolic acid A (SA-A) on liver injury: SA-A action on hepatic peroxidation. Liver. 2001;21:384-90.
23. Wagner FM, Weber AT, Ploetze K, Schubert F, Pfeiffer S, Albrecht S, et al. Do vitamins C and E attenuate the effects of reactive oxygen species during pulmonary reperfusion and thereby prevent injury? Ann Thorac Surg. 2002;74:811-7.
24. Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994;42:276-8.
25. Prasad K, Chan WP, Bharadwaj B. Superoxide dismutase and catalase in protection of cardiopulmonary bypass-induced cardiac dysfunction and cellular injury. Can J Cardiol. 1996;12:1083-91.
26. Rossi GP, Seccia TM, Albertin G, Pessina AC. Measurement of endothelin: clinical and research use. Ann Clin Biochem. 2000;37(Pt 5):608-26.
27. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991;84:2280-5.
28. Prins BA, Hu RM, Nazario B, Pedram A, Frank HJ, Weber MA, et al. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem. 1994;269: 11938-44.
29. Razandi M, Pedram A, Rubin T, Levin ER. PGE2 and PGI2 inhibit ET-1 secretion from endothelial cells by stimulating particulate guanylate cyclase. Am J Physiol. 1996;270(4 Pt 2):H1342-9.
30. Adatia I, Barrow SE, Stratton PD, Ritter JM, Haworth SG. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. Br Heart J. 1994;72:452-6.